2024년 03월 28일 목요일
뉴스홈 국제
Japan eyes approving Moderna’s COVID-19 vaccine for ages 12-17

[서울=아시아뉴스통신] 레악카나기자 송고시간 2021-06-13 03:00

Adolescents aged 12 to 17 soon approved to receive Moderna’s COVID-19 vaccine. (Photo by = Kyodo)

[Asia News = Reporter Reakkana] TOKYO - Japan is in the process of approving Moderna Inc.'s COVID-19 vaccine for use on adolescents aged 12 to 17, the government's top spokesman said Friday, Kyodo reported.  A panel at the Ministry of Health, Labor and Welfare will consider lowering the age limit for the shot, which has already been given the green light for people aged 18 and older, "if the efficacy and safety is confirmed and the guidelines are amended," Chief Cabinet Secretary Katsunobu Kato said at a press conference.

 Moderna's Japanese partner Takeda Pharmaceutical Co. is already in talks with the ministry, Kato said, setting up the vaccine to become the second available to adolescents in the country after Pfizer Inc. received approval in late May. On Thursday, Moderna said it has asked the U.S. Food and Drug Administration for emergency use authorization of the shot for ages 12 to 17 after clinical trials on nearly 2,500 subjects showed a 100 percent efficacy rate with no significant health concerns to date.

Japan is currently administering COVID-19 vaccines to health care workers and people aged 65 and older, with the so-far sluggish rollout to ramp up significantly in the coming days as it expands to all age groups.


 

[ 저작권자 © 아시아뉴스통신. 무단 전재 및 재배포금지]



제보전화 : 1644-3331    이기자의 다른뉴스보기
의견쓰기

댓글 작성을 위해 회원가입이 필요합니다.
회원가입 시 주민번호를 요구하지 않습니다.

실시간 급상승 정보

포토뉴스

more